Botulism, botulinum toxin, and bioterrorism: Review and update

Infections in Medicine

Volumn 21, Issue 6, 2004, Pages 284-290

  Koirala, Janak ^a   Basnet, Sangita ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Midwest Neopeds Associates   (United States)

Author keywords

Bioterrorism; Botulinum toxin; Botulism

Indexed keywords

BACTERIAL VACCINE; BOTULINUM ANTISERUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXOID; BOTULINUM VACCINE; PENICILLIN G; TOXOID; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BIOLOGICAL WARFARE; BOTULISM; BULBAR PARALYSIS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLOSTRIDIUM BOTULINUM; DRUG HYPERSENSITIVITY; FLACCID PARALYSIS; HUMAN; NEUROMUSCULAR DISEASE; NONHUMAN; PASSIVE IMMUNIZATION; REVIEW; SENSORY SYSTEM; SERUM SICKNESS; URTICARIA;

EID: 3242667943     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Erbguth FJ, Naumann M. Historical aspects of Botulinum. toxin: Justinus Kerner (1786-1862) and "sausage poison." Neurology. 1999;53:1850-1853.
2. Kreyden OP, Geiges ML, Boni R, Burg G. Botulinum toxin: from poison to drug. A historical review [in German]. Hautarzt. 2000;51:733-737.
3. Suen JC, Hatheway CL, Steigerwalt AG, Brenner DJ. Genetic confirmation of identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of infant botulism. J Clin Microbiol. 1988;26:2191-2192.
4. Middlebrook JL, Franz DR. Botulinum toxins. In: Sidell FR, Takafuji ET, Franz DR, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General; 1997:643-654.
5. Arnon SS, Schechter R, Inglesby T, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001; 285:1059-1070.
6. Carruthers A, Carruthers J. Update on the botulinum neurotoxins. Skin Therapy Lett. 2001;6:1-2.
7. National Drug Data File (NDDF) from First Data Bank. Available at: www.medscape.com. Accessed April 5, 2004.
8. Centers for Disease Control and Prevention. Surveillance for botulism summary of 2001 data. Available at: http://www.cdc.gov/ncidod/dbmd/diseasinfo/files/BotCSTE2001.pdf. Accessed April 5, 2004.
9. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiological review. Ann Intern Med. 1998;129: 221-228.
10. Holzer VE. Botulism from inhalation. Med Klin. 1962;57:1735-1738.
11. Centers for Disease Control and Prevention. Botulism in the United States 1899-1996: handbook for epidemiologists, clinicians, and laboratory workers. Atlanta: Centers for Disease Control and Prevention; 1998. Available at: http://www.bt.cdc.gov/agent/botulism/index.asp. Accessed April 5, 2004.
12. Werner SB, Passaro D, McGee J, et al. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis. 2000; 31:1018-1024.
13. Merson MH, Dowell VR Jr. Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med. 1973;289:1005-1010.
14. Cherington M. Clinical spectrum of botulism. Muscle Nerve. 1998;21:701-710.
15. Padua L, Aprile I, Monaco ML, et al. Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG. Muscle Nerve. 1999;22:1388-1392.
16. Centers for Disease Control and Prevention, American Society for Microbiology, Association of Public Health Laboratories. Laboratory Response Network (LRN): level A laboratory guidelines for identification of Clostridium botulinum toxin, updated: 5/13/03. Available at: http://www.bt.cdc.gov/labissues/index.asp. Accessed April 5, 2004.
17. Franciosa G, Ferreira JL, Hatheway CL. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J Clin Microbiol. 1994;32:1911-1917.
18. Ferreira JL, Eliasberg SJ, Harrison MA, Edmonds P, et al. Detection of preformed type A botulinal toxin in hash brown potatoes by using the mouse bioassay and modified ELISA test. J AOAC Int. 2001;84:1460-1464.
19. Bioterrorism Information Resources. Botulinum toxin. Infectious Disease Society of America, Alexandria, Va. Last updated: December 22, 2003. Available at: http://www.idsociety.org/ Template.cfm?Section=Bioterrorism&CONTENTID=8096&TEMPLATE. Accessed April 5, 2004.
20. Shen WP, Felsing N, Lang D, et al. Development of infant botulism in a 3-year-old female with neuroblastoma following autologous bone marrow transplantation: potential use of human botulism immune globulin. Bone Marrow Transplant. 1994;13:345-347.
21. Kortepeter MM, Christopher G, Cieslak T, et al. Bululinum. In: USAMRIID's Medical Management of Biological Casualties Handbook. 4th ed. Fort Dietrick, Md: US Army Medical Research Institute of Infectious Diseases; 2001:70-75.
22. Santos JI, Swensen P, Glasgow LA. Potentiation of Clostridium botulinum toxin by aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics. 1981;68:50-54.
23. Schulze J, Toepfer K, Schroff KC, et al. Clindamycin and nicotinic neuromuscular transmission. Lancet. 1999;354:1792-1793.
24. Pittman PR, Hack D, Mangiafico J, Gibbs P. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine. 2002;20:2107-2115.
25. Centers for Disease Control and Prevention. Drug service - immunobiologics distributed by the Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncidod/dpd/professional/drgsrv_immunobiologics.htm. Accessed April 5, 2004.
26. Torii Y, Tokumaru Y, Kawaguchi S, et al. Production and immunogenic efficacy of botulinum tetravalent (A,B,E,F) toxoid. Vaccine. 2002;20:2556-2561.
27. Lee JS, Pushko P, Parker MD, et al. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun. 2001; 69:5709-5715.
28. Park JB, Simpson LL. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun. 2003;71:1147-1154.
29. Shapiro RL, Hatheway C, Becher J, Swerdlow DL. Botulism surveillance and emergency response. A public health strategy for a global challenge. JAMA. 1997;278:433-435.
30. Centers for Disease Control and Prevention. Notice to readers: new telephone number to report botulism cases and request antitoxin. MMWR. 2003;52:774.